Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LGND | Common Stock | Award | $0 | +1K | +4.01% | $0.00 | 26.1K | Jun 10, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LGND | Non-Qualified Stock Option (right to buy) | Award | $0 | -4.34K | -50% | $0.00 | 4.34K | Jun 10, 2022 | Common Stock | 4.34K | $79.29 | Direct | F2 |
holding | LGND | Non-Qualified Stock Option (right to buy) | 3.27K | Jun 10, 2022 | Common Stock | 3.27K | $115.39 | Direct | F3 |
Id | Content |
---|---|
F1 | These securities, as represented in Column 5, include a grant of 1,004 restricted share units approved by the Board of Directors of the Company at the 2022 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. |
F2 | These securities, as represented in Column 5, were acquired by a grant of 4,340 shares approved by the Board of Directors of the Company at the 2022 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time. |
F3 | These securities, as represented in Column 5, were acquired by a grant of 3,269 shares approved by the Board of Directors of the Company at the 2021 Meeting and are fully vested and exerciseable as more fully described on a Form 4 for this Reporting Person filed on June 8, 2021. |